Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Value of combined PET/contrast-enhanced high-resolution CT fusion imaging for lung cancer.
Lacout A, Marcy PY, Thariat J.
AJR Am J Roentgenol. 2012 Jan;198(1):W99; author reply W100. No abstract available.
Related citations
Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity?
Kim TJ, Park CM, Goo JM, Lee KW.
AJR Am J Roentgenol. 2012 Jan;198(1):83-8.
Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy.
Ohno Y, Koyama H, Yoshikawa T, Matsumoto K, Aoyama N, Onishi Y, Sugimura K.
AJR Am J Roentgenol. 2012 Jan;198(1):75-82.
A weighting approach to causal effects and additive interaction in case-control studies: marginal structural linear odds models.
VanderWeele TJ, Vansteelandt S.
Am J Epidemiol. 2011 Nov 15;174(10):1197-203. Epub 2011 Oct 19.
Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer.
Smit EF, Socinski MA, Mullaney BP, Myrand SP, Scagliotti GV, Lorigan P, Reck M, Ciuleanu T, von Pawel J, Karaseva NA, Szczesna A, Ohannesian D, Powell E, Hozak RR, Hong S, Guba SC, Thatcher N.
Ann Oncol. 2011 Dec 19. [Epub ahead of print]
Host-derived MMP-13 exhibits a protective role in lung metastasis of melanoma cells by local endostatin production.
Fukuda H, Mochizuki S, Abe H, Okano HJ, Hara-Miyauchi C, Okano H, Yamaguchi N, Nakayama M, D'Armiento J, Okada Y.
Br J Cancer. 2011 Nov 8;105(10):1615-24. doi: 10.1038/bjc.2011.431. Epub 2011 Oct 20.
Pharmacokinetics of carboplatin in a hemodialysis patient with small-cell lung cancer.
Hiraike M, Hiraki Y, Misumi N, Hanada K, Tsuji Y, Kamimura H, Karube Y, Kashiwabara K.
Cancer Chemother Pharmacol. 2012 Mar;69(3):845-8. Epub 2011 Dec 23.
CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice.
Pei KL, Yuan Y, Qin SH, Wang Y, Zhou L, Zhang HL, Qu XJ, Cui SX.
Cancer Chemother Pharmacol. 2012 Apr;69(4):1029-38. Epub 2011 Dec 21.
NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCι/FAK loop.
Shen J, Xu L, Owonikoko TK, Sun SY, Khuri FR, Curran WJ, Deng X.
Cancer Lett. 2012 May 1;318(1):106-13. Epub 2011 Dec 13.
The heat shock protein 90 inhibitor, AT13387, displays a long duration of action in vitro and in vivo in non-small cell lung cancer.
Graham B, Curry J, Smyth T, Fazal L, Feltell R, Harada I, Coyle J, Williams B, Reule M, Angove H, Cross DM, Lyons J, Wallis NG, Thompson NT.
Cancer Sci. 2012 Mar;103(3):522-7. doi: 10.1111/j.1349-7006.2011.02191.x. Epub 2012 Feb 9.
Comparison of (11)C-Choline PET/CT and Enhanced CT in the Evaluation of Patients With Pulmonary Abnormalities and Locoregional Lymph Node Involvement in Lung Cancer.
Peng Z, Liu Q, Li M, Han M, Yao S, Liu Q.
Clin Lung Cancer. 2011 Dec 17. [Epub ahead of print]
Prognostic Role of Twist, Slug, and Foxc2 Expression in Stage I Non-Small-Cell Lung Cancer After Curative Resection.
Jiang W, Pang XG, Wang Q, Shen YX, Chen XK, Xi JJ.
Clin Lung Cancer. 2011 Dec 15. [Epub ahead of print]
Functional genetic variants of c-Jun and their interaction with smoking and drinking increase the susceptibility to lung cancer in southern and eastern Chinese.
Huang B, Liu B, Yang L, Li Y, Cheng M, Huang D, Wang H, Zhang X, Zheng J, Li Q, Ji W, Zhou Y, Lu J.
Int J Cancer. 2011 Dec 20. doi: 10.1002/ijc.27407. [Epub ahead of print]
A synthetic compound, 1,5-bis(2-methoxyphenyl)penta- 1,4-dien-3-one (B63), induces apoptosis and activates endoplasmic reticulum stress in non-small cell lung cancer cells.
Xiao J, Wang Y, Peng J, Guo L, Hu J, Cao M, Zhang X, Zhang H, Wang Z, Li X, Yang S, Yang H, Liang G.
Int J Cancer. 2011 Dec 20. doi: 10.1002/ijc.27406. [Epub ahead of print]
Drug resistance to paclitaxel is not only associated with ABCB1 mRNA expression but also with drug accumulation in intracellular compartments in human lung cancer cell lines.
Shimomura M, Yaoi T, Itoh K, Kato D, Terauchi K, Shimada J, Fushiki S.
Int J Oncol. 2012 Apr;40(4):995-1004. doi: 10.3892/ijo.2011.1297. Epub 2011 Dec 13.
Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer: in regards to Register et al. Int J Radiat Oncol Biol Phys 2011;80:1015-1022.
Bongers EM, Dahele MR, Slotman BJ, Senan S, Bot JC.
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):492; author reply 492. No abstract available.
Computed tomography-based simulation for thoracic radiation therapy: technical advance or clinical evidence?
Levy A, Magné N, Chargari C.
J Clin Oncol. 2011 Nov 10;29(32):4335-6; author reply 4336. Epub 2011 Oct 11. No abstract available.
Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study.
Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, Hoskin PJ, Lister TA, Radford JA, Rohatiner AZ, Linch DC.
J Clin Oncol. 2011 Nov 1;29(31):4096-104. Epub 2011 Oct 3.
Oxaliplatin-induced coronary vasospasm manifesting as Kounis syndrome: a case report.
Chang PH, Hung MJ, Yeh KY, Yang SY, Wang CH.
J Clin Oncol. 2011 Nov 1;29(31):e776-8. Epub 2011 Oct 3. No abstract available.
Perspectives of patients on the utility of electronic patient-reported outcomes on cancer care.
Seow H, King S, Green E, Pereira J, Sawka C.
J Clin Oncol. 2011 Nov 1;29(31):4213-4. Epub 2011 Sep 19. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on